Rheumatology and Therapy

Scope & Guideline

Pioneering research that transforms patient outcomes.

Introduction

Immerse yourself in the scholarly insights of Rheumatology and Therapy with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN2198-6576
PublisherSPRINGER
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2014 to 2024
AbbreviationRHEUMATOL THER / Rheumatol. Ther.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The journal 'Rheumatology and Therapy' is dedicated to advancing research in the field of rheumatology, focusing on the comprehensive understanding of therapeutic strategies, patient outcomes, and the management of rheumatic diseases. It emphasizes clinical efficacy, safety, and patient-reported outcomes, contributing valuable insights into treatment protocols and healthcare practices.
  1. Clinical Effectiveness and Safety of Therapies:
    The journal investigates the efficacy and safety profiles of various biological and targeted therapies in treating conditions such as rheumatoid arthritis, psoriatic arthritis, and systemic lupus erythematosus.
  2. Real-World Evidence and Patient Outcomes:
    A significant focus is placed on real-world data studies that assess treatment patterns, patient adherence, and health outcomes, providing insights into everyday clinical practice.
  3. Comparative Effectiveness Research:
    The journal frequently publishes comparative studies assessing the effectiveness of different therapeutic agents, including head-to-head trials and indirect comparisons, to guide clinicians in making informed treatment decisions.
  4. Patient-Reported Outcomes and Quality of Life:
    Research on patient-reported outcomes (PROs) is central to understanding the impact of diseases and treatments on patients' quality of life, helping to shape future therapeutic approaches.
  5. Emerging Therapies and Mechanisms of Action:
    The journal explores novel treatment modalities and the underlying mechanisms of action of biologics and small molecules, contributing to the advancement of personalized medicine in rheumatology.
The journal 'Rheumatology and Therapy' has seen emerging trends and themes that reflect the evolving landscape of rheumatologic research. These themes indicate areas of growing interest and relevance to both researchers and clinicians.
  1. Biologics and Targeted Therapies:
    There is a strong trend towards research on the safety and efficacy of biologics and targeted therapies, such as JAK inhibitors and IL-17 inhibitors, in various rheumatic diseases, highlighting their increasing role in treatment protocols.
  2. Real-World Data and Pragmatic Trials:
    An increasing number of publications are focusing on real-world data and pragmatic trials, offering insights into how treatments perform outside of the controlled clinical trial environment, which is critical for clinical application.
  3. Health Disparities and Patient Demographics:
    Emerging research themes include the exploration of racial and ethnic disparities in treatment responses and healthcare access among rheumatology patients, reflecting a growing awareness of social determinants of health.
  4. Patient Experience and Satisfaction:
    Research focusing on patient experience, including satisfaction with treatment and communication with healthcare providers, is gaining traction, emphasizing the importance of patient-centered care.
  5. Longitudinal Outcomes and Treatment Retention:
    There is an increasing emphasis on studies examining long-term outcomes and treatment retention rates among patients receiving various therapies, which are crucial for understanding the sustainability of treatment efficacy.

Declining or Waning

While 'Rheumatology and Therapy' continues to thrive in various research areas, some themes have shown a decline in focus over recent years. This trend may reflect shifting priorities within the field or advancements in understanding that render certain topics less prominent.
  1. Traditional Disease-Modifying Anti-Rheumatic Drugs (DMARDs):
    There appears to be a waning interest in studies focused solely on traditional DMARDs, as newer therapies and biologics gain prominence in clinical research.
  2. Non-Pharmacological Interventions:
    Research on non-pharmacological interventions, such as physical therapy and lifestyle modifications, has decreased in favor of pharmacological studies, indicating a shift towards more intensive treatment approaches.
  3. Longitudinal Studies of Established Treatments:
    The frequency of longitudinal studies examining the long-term effects of established treatments has diminished, possibly due to an increasing focus on newer agents and their rapid evaluation.
  4. Epidemiological Studies in Established Populations:
    There is a noticeable decline in epidemiological studies focusing on established populations with rheumatic diseases, as the journal pivots towards more dynamic and emergent research themes.
  5. General Reviews of Rheumatic Diseases:
    General reviews lacking a specific focus on recent advancements or novel insights have become less common, reflecting a trend towards more targeted and detailed research articles.

Similar Journals

Arthritis & Rheumatology

Empowering Global Collaboration in Rheumatology
Publisher: WILEYISSN: 2326-5191Frequency: 12 issues/year

Arthritis & Rheumatology is a leading journal dedicated to the advancement of knowledge in the fields of rheumatology, immunology, and allergy. Published by WILEY in the United Kingdom, this prestigious journal boasts an impressive impact factor and a prominent reputation, ranking in the Q1 category across multiple disciplines, including Immunology and Rheumatology. With its high ranking of 4th out of 73 in Rheumatology and notable standings in related fields, it serves as a crucial platform for researchers, healthcare professionals, and scholars to disseminate groundbreaking findings. The journal embraces an Open Access model, enhancing the accessibility of vital research to a global audience and ensuring that knowledge dissemination is maximized. Since its inception in 2014, Arthritis & Rheumatology has been at the forefront of impactful research, fostering collaboration and innovation in tackling complex challenges within these medical disciplines. Researchers looking to explore the latest advancements and engage with cutting-edge studies in these fields will find this journal to be an essential resource.

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders

Empowering clinicians through cutting-edge insights.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5441Frequency: 1 issue/year

Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders, published by SAGE PUBLICATIONS LTD, is an esteemed open-access journal dedicated to advancing knowledge in the field of rheumatology and related immunological disorders. Since its inception in 2008, the journal has provided a platform for researchers and clinicians from around the world to disseminate cutting-edge studies and insights into arthritis and musculoskeletal conditions. Based in New Zealand, this journal has maintained a commendable standing in academic circles, evidenced by its Q3 quartile rankings in both Immunology and Allergy and Rheumatology categories for 2023, alongside respectable Scopus rankings. The journal serves as a vital resource for healthcare professionals, researchers, and students, facilitating enhanced understanding and treatment of musculoskeletal disorders through high-quality research and peer-reviewed articles. With a focus on fostering interdisciplinary collaboration and innovation in the field, Clinical Medicine Insights-Arthritis and Musculoskeletal Disorders is essential reading for those committed to improving patient outcomes and advancing scientific knowledge.

Modern Rheumatology

Advancing the Future of Rheumatology
Publisher: OXFORD UNIV PRESSISSN: 1439-7595Frequency: 6 issues/year

Modern Rheumatology is a premier journal dedicated to advancing the field of rheumatology through high-quality peer-reviewed research. Published by Oxford University Press, this journal reflects the latest developments in rheumatologic medicine, catering to researchers, clinicians, and students alike. With an H-Index highlighting its scholarly impact, Modern Rheumatology occupies a notable position, ranking Q2 in both the fields of Medicine and Rheumatology in 2023, and is listed among the top 25 journals in its category by Scopus. Spanning from the year 2000 to 2024, the journal features a diverse array of topics aimed at addressing current challenges and innovations in the field. Although it does not offer Open Access, it provides essential insights for professionals seeking to stay abreast of evolving treatment modalities and research breakthroughs. Located in the heart of the United Kingdom, Modern Rheumatology is a vital resource for anyone committed to enhancing the understanding and treatment of rheumatic diseases.

Current Rheumatology Reviews

Pioneering insights for modern rheumatology.
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-3971Frequency: 3 issues/year

Current Rheumatology Reviews is an esteemed journal dedicated to publishing comprehensive reviews on advancements in the field of rheumatology. Established by Bentham Science Publishers, this journal has become a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments and therapeutic strategies from 2006 to 2024. Located in the United Arab Emirates, it caters to a global audience, delivering insights that have been pivotal in shaping clinical practices. With an impact factor reflective of its Q3 status in Rheumatology by 2023, the journal ranks #46 out of 73 in the Scopus database, positioning it in the 37th percentile in the discipline. Although it operates without open access, its high-quality content ensures that each article undergoes rigorous peer review, making the Current Rheumatology Reviews a trusted platform for disseminating critical research findings and reviews that drive forward the understanding and treatment of rheumatic diseases.

CURRENT OPINION IN RHEUMATOLOGY

Shaping the Future of Rheumatology Through Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 1040-8711Frequency: 6 issues/year

Current Opinion in Rheumatology, published by Lippincott Williams & Wilkins, stands as a vital resource in the field of rheumatology. Since its inception in 1989, this prestigious journal has been at the forefront of disseminating cutting-edge research, with a notable Q1 ranking in the 2023 Rheumatology category and an impressive Scopus rank of 7 out of 73, placing it in the 91st percentile. The journal's commitment to presenting insightful reviews and critical analyses of recent advancements and treatment strategies makes it an essential read for professionals, researchers, and students dedicated to the study of rheumatic diseases. Although not an open-access journal, Current Opinion in Rheumatology continues to foster an informed dialogue within the academic community through its high-impact content, ensuring that the latest developments and practices are accessible to those at the vanguard of rheumatology research.

Open Access Rheumatology-Research and Reviews

Transforming Rheumatology Research through Accessibility.
Publisher: DOVE MEDICAL PRESS LTDISSN: 1179-156XFrequency: 1 issue/year

Open Access Rheumatology-Research and Reviews, published by DOVE MEDICAL PRESS LTD, is a distinguished journal that has been a vital part of the rheumatology field since its inception in 2009. With an ISSN of 1179-156X, this journal is dedicated to disseminating groundbreaking research and comprehensive reviews in the discipline of rheumatology, making it an essential resource for researchers, clinicians, and students alike. It boasts an impressive Q3 ranking in the Rheumatology category for 2023, reflecting its relevance and quality within a highly competitive landscape, where it ranks in the 51st percentile among its peers as indicated by the Scopus Ranks. As an open-access platform, it ensures that critical findings and insights are easily accessible to a global audience, promoting collaboration and knowledge sharing. The journal's scope includes a wide range of topics within rheumatology, aimed at advancing understanding and treatment of musculoskeletal disorders and autoimmune diseases. Its headquarters is located in New Zealand, positioning it as a key player in the international research community.

ImmunoTargets and Therapy

Fostering Global Collaboration in Immunology
Publisher: DOVE MEDICAL PRESS LTDISSN: Frequency: 1 issue/year

ImmunoTargets and Therapy is a leading open access journal published by DOVE MEDICAL PRESS LTD, dedicated to advancing the field of immunology and its various therapeutic applications. Since its inception in 2012, the journal has rapidly become a vital resource for researchers, professionals, and students, achieving notable recognition with a Q1 ranking in both Immunology and Immunology and Allergy categories as of 2023. With an impressive Scopus ranking of #22 out of 233 in Medicine - Immunology and Allergy, and #25 out of 236 in Immunology and Microbiology, this journal maintains a 90th percentile standing in its field. ImmunoTargets and Therapy not only publishes original research articles, reviews, and clinical studies, but also fosters an inclusive platform for the dissemination of innovative findings critical to the fight against immunological disorders. Based in New Zealand, it serves a global audience, promoting knowledge exchange and collaboration through its open access model.

Lancet Rheumatology

Unveiling the latest breakthroughs in rheumatological research.
Publisher: ELSEVIERISSN: 2665-9913Frequency: 12 issues/year

The Lancet Rheumatology, published by Elsevier, is a premier academic journal dedicated to advancing the understanding of rheumatology and immunological diseases. Launched in 2019, this esteemed publication has quickly become a leading source of research, achieving an impressive Q1 ranking in both the fields of Rheumatology and Immunology as of 2023. With Scopus rankings placing it at #2 out of 73 in Medicine - Rheumatology and #6 out of 233 in Medicine - Immunology and Allergy, the journal serves as an essential platform for disseminating high-quality, peer-reviewed articles that address the latest findings and clinical practices in these domains. The journal, accessible in print and online, is committed to fostering knowledge and collaboration among researchers, healthcare professionals, and students alike, making it an invaluable resource for those seeking to deepen their expertise in rheumatology and its interrelated fields.

Pediatric Rheumatology

Advancing pediatric care through groundbreaking research.
Publisher: BMCISSN: Frequency: 1 issue/year

Pediatric Rheumatology is a leading peer-reviewed open access journal published by BMC, dedicated to disseminating high-quality research in the field of pediatric rheumatology. Since its inception in 2007, the journal has established itself as a vital resource for healthcare professionals, researchers, and students focused on pediatric immunology, rheumatology, and child health, maintaining an impressive Q1 ranking in Pediatrics and Q2 in Immunology and Allergy as well as Rheumatology for 2023. It is recognized for its impact on advancing knowledge and clinical practice, with significant contributions noted in various studies and case reports. With access options that embrace the ethos of open science, all articles published in Pediatric Rheumatology are freely available, promoting collaborative research and discussion among practitioners across the globe. The journal welcomes submissions that encapsulate innovative research, clinical trials, and reviews that address both current challenges and advancements within the pediatric rheumatology landscape.

ARP Rheumatology

Fostering Excellence in Rheumatology Scholarship
Publisher: Sociedade Portuguesa ReumatologiaISSN: 2795-4552Frequency: 4 issues/year

ARP Rheumatology is a pioneering open-access journal dedicated to the field of rheumatology, published by the esteemed Sociedade Portuguesa Reumatologia. Since its inception in 2022, this journal has aimed to bridge the gap between research and clinical practice, providing a platform for the dissemination of high-quality research, case studies, and reviews that advance the understanding and management of rheumatic diseases. Although currently classified in the Q4 category of rheumatology journals with a Scopus rank of 56/73, our commitment to academic excellence and engagement with our readership is unwavering. Located in Portugal, ARP Rheumatology supports a global community of researchers, professionals, and students by maintaining rigorous peer-review standards and promoting innovative scientific discourse. With accessible content and a focus on the latest advancements in the field, ARP Rheumatology is poised to make a significant impact on the future of rheumatology research and practice.